PMC Articles for MedGen (Select 272713) - PMC

Select item 98265751.

Clinical application of PARP inhibitors in ovarian cancer: from molecular mechanisms to the current status

Yongsong Wu, Shilin Xu, Shanshan Cheng, Jiani Yang, Yu Wang

J Ovarian Res. 2023; 16: 6. Published online 2023 Jan 7. doi: 10.1186/s13048-023-01094-5

PMCID:: PMC9826575

Select item 89929882.

A randomized controlled trial comparing self-referred message to family-referred message promoting men’s adherence to evidence-based guidelines on BRCA1/2 germline genetic testing: A registered study protocol

Serena Petrocchi, Giulia Ongaro, Mariarosaria Calvello, Irene Feroce, Bernardo Bonanni, Gabriella Pravettoni

PLoS One. 2022; 17(4): e0266327. Published online 2022 Apr 8. doi: 10.1371/journal.pone.0266327

PMCID:: PMC8992988

Abstract Article PDF–920K

Select item 88429113.

Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline

Panagiotis A. Konstantinopoulos, Barbara Norquist, Christina Lacchetti, Deborah Armstrong, Rachel N. Grisham, Paul J. Goodfellow, Elise C. Kohn, Douglas A. Levine, Joyce F. Liu, Karen H. Lu, Dorinda Sparacio, Christina M. Annunziata

J Clin Oncol. Author manuscript; available in PMC 2022 Feb 14.

Published in final edited form as: J Clin Oncol. 2020 Apr 10; 38(11): 1222–1245. Published online 2020 Jan 27. doi: 10.1200/JCO.19.02960

PMCID:: PMC8842911

Abstract Article PDF–203K

Select item 88342074.

Hereditary Ovarian Carcinoma: Cancer Pathogenesis Looking beyond BRCA1 and BRCA2

David Samuel, Alexandra Diaz-Barbe, Andre Pinto, Matthew Schlumbrecht, Sophia George

Cells. 2022 Feb; 11(3): 539. Published online 2022 Feb 4. doi: 10.3390/cells11030539

PMCID:: PMC8834207

Abstract Article PDF–1.5M

Select item 70629835.

Genetic counseling of patients with ovarian carcinoma: acceptance, timing, and psychological wellbeing

I. Van de Beek, E. M. A. Smets, M. A. Legdeur, J. A. de Hullu, C. A. R. Lok, M. R. Buist, M. J. E. Mourits, C. M. Kets, L. E. van der Kolk, J. C. Oosterwijk, C. M. Aalfs

J Community Genet. 2020 Apr; 11(2): 183–191. Published online 2019 Jun 5. doi: 10.1007/s12687-019-00427-6

PMCID:: PMC7062983

Abstract Article PDF–477K

Select item 63207156.

Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort

Jingmei Li, Wei Xiong Wen, Martin Eklund, Anders Kvist, Mikael Eriksson, Helene Nordahl Christensen, Astrid Torstensson, Svetlana Bajalica‐Lagercrantz, Alison M. Dunning, Brennan Decker, Jamie Allen, Craig Luccarini, Karen Pooley, Jacques Simard, Leila Dorling, Douglas F. Easton, Soo‐Hwang Teo, Per Hall, Åke Borg, Henrik Grönberg, Kamila Czene

Int J Cancer. 2019 Mar 1; 144(5): 1195–1204. Published online 2018 Nov 9. doi: 10.1002/ijc.31841

PMCID:: PMC6320715

Abstract Article PDF–1.2M

Select item 57167587.

Increased single-strand annealing rather than non-homologous end-joining predicts hereditary ovarian carcinoma

Miriam Deniz, Tatiana Romashova, Sarah Kostezka, Anke Faul, Theresa Gundelach, Maria Moreno-Villanueva, Wolfgang Janni, Thomas W.P. Friedl, Lisa Wiesmüller

Oncotarget. 2017 Nov 17; 8(58): 98660–98676. Published online 2017 Oct 9. doi: 10.18632/oncotarget.21720

PMCID:: PMC5716758

Abstract Article PDF–2.8M

Select item 55013608.

Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based Outreach

Goli Samimi, Marcus Q. Bernardini, Lawrence C. Brody, Charlisse F. Caga-anan, Ian G. Campbell, Georgia Chenevix-Trench, Fergus J. Couch, Michael Dean, Joanne A. de Hullu, Susan M. Domchek, Ronny Drapkin, Heather Spencer Feigelson, Michael Friedlander, Mia M. Gaudet, Marline G. Harmsen, Karen Hurley, Paul A. James, Janice S. Kwon, Felicitas Lacbawan, Stephanie Lheureux, Phuong L. Mai, Leah E. Mechanic, Lori M. Minasian, Evan R. Myers, Mark E. Robson, Susan J. Ramus, Lisa F. Rezende, Patricia A. Shaw, Thomas P. Slavin, Elizabeth M. Swisher, Masataka Takenaka, David D. Bowtell, Mark E. Sherman

J Clin Oncol. 2017 Jul 10; 35(20): 2329–2337. Published online 2017 Apr 11. doi: 10.1200/JCO.2016.70.3439

PMCID:: PMC5501360

Abstract Article PDF–861K

Select item 48294759.

Patient Perceptions of Telephone vs. In-Person BRCA1/BRCA2 Genetic Counseling

Beth N. Peshkin, Scott Kelly, Rachel H. Nusbaum, Morgan Similuk, Tiffani A. DeMarco, Gillian W. Hooker, Heiddis B. Valdimarsdottir, Andrea D. Forman, Jessica Rispoli Joines, Claire Davis, Shelley R. McCormick, Wendy McKinnon, Kristi D. Graves, Claudine Isaacs, Judy Garber, Marie Wood, Lina Jandorf, Marc D. Schwartz

J Genet Couns. Author manuscript; available in PMC 2017 Jun 1.

Published in final edited form as: J Genet Couns. 2016 Jun; 25(3): 472–482. Published online 2015 Oct 12. doi: 10.1007/s10897-015-9897-6

PMCID:: PMC4829475

Abstract Article PDF–228K

Select item 475963910.

Prevalence and Healthcare Actions of Women in a Large Health System with a Family History Meeting the 2005 USPSTF Recommendation for BRCA Genetic Counseling Referral

Cecelia A. Bellcross, Steven Leadbetter, Sharon Hensley Alford, Lucy A. Peipins

Cancer Epidemiol Biomarkers Prev. Author manuscript; available in PMC 2016 Feb 19.

Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2013 Apr; 22(4): 728–735. Published online 2013 Jan 31. doi: 10.1158/1055-9965.EPI-12-1280

PMCID:: PMC4759639

Abstract Article PDF–206K

Select item 474217911.

On representing the prognostic value of continuous gene expression biomarkers with the restricted mean survival curve

Kevin H. Eng, Emily Schiller, Kayla Morrell

Oncotarget. 2015 Nov 3; 6(34): 36308–36318. Published online 2015 Oct 14. doi: 10.18632/oncotarget.6121

PMCID:: PMC4742179

Abstract Article PDF–1.7M

Select item 468974912.

SEOM clinical guidelines in Hereditary Breast and ovarian cancer

G. Llort, I. Chirivella, R. Morales, R. Serrano, A. Beatriz Sanchez, A. Teulé, E. Lastra, J. Brunet, J. Balmaña, B. Graña, On behalf of the SEOM Hereditary Cancer Working Group

Clin Transl Oncol. 2015; 17: 956–961. Published online 2015 Dec 15. doi: 10.1007/s12094-015-1435-3

PMCID:: PMC4689749

Abstract Article PDF–363K

Select item 461819913.

655Val and 1170Pro ERBB2 SNPs in Familial Breast Cancer Risk and BRCA1 Alterations

Stefania Tommasi, Vita Fedele, Rosanna Lacalamita, Michele Bruno, Francesco Schittulli, David Ginzinger, Gery Scott, Serenella Eppenberger-Castori, Daniele Calistri, Silvia Casadei, Ian Seymour, Salvatore Longo, Gianluigi Giannelli, Brunella Pilato, Giovanni Simone, Christopher C. Benz, Angelo Paradiso

Cell Oncol. 2007; 29(3): 241–248. Published online 2007 Apr 23. doi: 10.1155/2007/512518

PMCID:: PMC4618199

Abstract PDF–88K

Select item 366257714.

Mutational analysis of BRCA1 and BRCA2 in hereditary breast and ovarian cancer families from Asturias (Northern Spain)

Pilar Blay, Iñigo Santamaría, Ana S Pitiot, María Luque, Marta G Alvarado, Ana Lastra, Yolanda Fernández, Ángeles Paredes, José MP Freije, Milagros Balbín

BMC Cancer. 2013; 13: 243. Published online 2013 May 17. doi: 10.1186/1471-2407-13-243

PMCID:: PMC3662577

Abstract Article PDF–969K

Select item 299615315.

Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer

Sandhya Pruthi, Bobbie S. Gostout, Noralane M. Lindor

Mayo Clin Proc. 2010 Dec; 85(12): 1111–1120. doi: 10.4065/mcp.2010.0414

PMCID:: PMC2996153

Abstract Article PDF–871K

Select item 297578316.

The Molecular Pathogenesis of Hereditary Ovarian Carcinoma: Alterations in the Tubal Epithelium of Women with BRCA1 and BRCA2 Mutations

Barbara M. Norquist, Rochelle L. Garcia, Kimberly H. Allison, Chris H. Jokinen, Lauren E. Kernochan, Catherine C. Pizzi, Bethany J. Barrow, Barbara A. Goff, Elizabeth M. Swisher

Cancer. Author manuscript; available in PMC 2011 Nov 15.

Published in final edited form as: Cancer. 2010 Nov 15; 116(22): 5261–5271. doi: 10.1002/cncr.25439

PMCID:: PMC2975783

Abstract Article PDF–3.9M

Select item 277828717.

Hereditary ovarian carcinoma: Heterogeneity, molecular genetics, pathology, and management

Henry T. Lynch, Murray Joseph Casey, Carrie L. Snyder, Chhanda Bewtra, Jane F. Lynch, Matthew Butts, Andrew K. Godwin

Mol Oncol. 2009 Apr; 3(2): 97–137. Published online 2009 Feb 21. doi: 10.1016/j.molonc.2009.02.004

PMCID:: PMC2778287

Abstract Article PDF–2.4M

Select item 197223918.

Familial ovarian cancer. How rare is it?

J. Allan B. Matheson, Hazel Matheson, Stella A. Anderson

J R Coll Gen Pract. 1981 Dec; 31(233): 743–745.

PMCID:: PMC1972239

Summary Page Browse PDF–456K

Select item 173427719.

Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks?

L Lodder, P Frets, R Trijsburg, E Meijers-Heijboer, J Klijn, H Duivenvoorden, A Tibben, A Wagner, C A van der Meer, P Devilee, C Cornelisse, M Niermeijer, m other

J Med Genet. 1999 Dec; 36(12): 906–913.

PMCID:: PMC1734277

Summary PDF–97K

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from MedGen

Items: 19

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity